{
    "code": "02019251",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019251",
    "time": "2020-02-25 12:08:40",
    "許可證字號": "衛署藥輸字第019251號",
    "註銷狀態": "已註銷",
    "註銷日期": "89\/10\/20",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "87\/07\/14",
    "發證日期": "81\/05\/22",
    "許可證種類": "製　劑",
    "舊證字號": "02014184",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201925104",
    "中文品名": "的確當注射劑",
    "英文品名": "DECADRON PHOSPHATE INJECTION",
    "適應症": "嚴重過敏性反應（如氣喘、藥物過敏、輸血過敏）急性休克、風濕性關節炎之局部治療",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DEXAMETHASONE (SODIUM PHOSPHATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北巿敦化南路二段２１６號十四樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0122000  MERCK &amp; CO.,INC.",
            "製造廠廠址": "WEST POINT,P.A. 19486 ,U.S.A.ONE MERCK DRIVE,WHITEHOUSE STATION,NEW JERSEY,USA",
            "製造廠公司地址": "ONE MERCK DRIVE,WHITEHOUSE STATION,NEW JERSEY,USA",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804009640",
            "成分名稱": "DEXAMETHASONE (SODIUM PHOSPHATE)",
            "含量描述": "4.0",
            "含量": "4.0000000000",
            "單位": "MG"
        }
    ]
}